Merus's (MRUS +1.8%) CEO, Ton Logtenberg, will step down, effective December 31, 2019; however, he will remain on as a senior advisor during the transition over the next year.

The company has nominated Dr. Sven (Bill) Ante Lundberg, currently a non-executive director, to succeed Dr. Logtenberg

Dr. Bill Lundberg joined Merus’s Board in June 2019, and brings 15+ years of experience; most recently, he served as Chief Scientific Officer at CRISPR Therapeutics.

Source link